Extracting physical chemistry from mechanics: a new approach to
  investigate DNA interactions with drugs and proteins in single molecule
  experiments by Rocha, M. S.
ar
X
iv
:1
50
4.
04
56
2v
1 
 [p
hy
sic
s.b
io-
ph
]  
17
 A
pr
 20
15
Extracting physical chemistry from mechanics: a new approach...
Extracting physical chemistry from mechanics: a new approach to investigate
DNA interactions with drugs and proteins in single molecule experiments
M. S. Rocha
1, a)
Laborato´rio de F´ısica Biolo´gica, Departamento de F´ısica, Universidade Federal de Vic¸osa. Av. P. H. Rolfs s/n,
CEP 36570-900, Vic¸osa, MG, Brazil.
(Dated: 2 May 2019)
In this review we focus on the idea of establishing connections between the mechanical properties of DNA-
ligand complexes and the physical chemistry of DNA-ligand interactions. This type of connection is interesting
because it opens the possibility of performing a robust characterization of such interactions by using only one
experimental technique: single molecule stretching. Furthermore, it also opens new possibilities in compar-
ing results obtained by very different approaches, in special when comparing single molecule techniques to
ensemble-averaging techniques. We start the manuscript reviewing important concepts of the DNA mechan-
ics, from the basic mechanical properties to the Worm-Like Chain model. Next we review the basic concepts
of the physical chemistry of DNA-ligand interactions, revisiting the most important models used to analyze
the binding data and discussing their binding isotherms. Then, we discuss the basic features of the single
molecule techniques most used to stretch the DNA-ligand complexes and to obtain force × extension data,
from which the mechanical properties of the complexes can be determined. We also discuss the character-
istics of the main types of interactions that can occur between DNA and ligands, from covalent binding to
simple electrostatic driven interactions. Finally, we present a historical survey on the attempts to connect
mechanics to physical chemistry for DNA-ligand systems, emphasizing a recently developed fitting approach
useful to connect the persistence length of the DNA-ligand complexes to the physicochemical properties of
the interaction. Such approach in principle can be used for any type of ligand, from drugs to proteins, even
if multiple binding modes are present.
PACS numbers: 87.80.Nj; 82.37.Rs; 87.14.gk; 87.80.Cc
Keywords: DNA, ligands, mechanical properties, persistence length, binding isotherm, physical chemistry
I. INTRODUCTION
The DNA molecule is the biological polymer related
to some of the most important vital processes, from the
storage and transmission of genetic information to the
translation of proteins. Its primary structure is usually
described as two parallel strands with a peculiar chemi-
cal structure based in complementary base-pairs, allow-
ing the replication of the molecule in an unmistakable
way1,2. The two DNA strands are arranged forming a
double-helix structure that sets important properties to
the molecule such as a well-defined negative charge den-
sity and a bending stiffness which places DNA in the class
of semi-flexible polymers3–6.
Since it stores the genetic information of an organ-
ism, the DNA molecule may be very long in some cases.
In fact, the human genome has approximately 3 billion
base pairs, corresponding to a linear contour length of
the order of 1 meter. If a DNA molecule with this length
is placed disperse in a water-based solution, its radius
of gyration will be of the order of 100 µm7. How can
a molecule with this size be stored in the nucleus of a
cell, which has typical dimensions on the order of a few
micrometers2? The answer lies, at least partially, in the
mechanical properties of the DNA molecule, which must
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be unique to allow such a condensation. In vivo, this
process usually occurs mediated by the interaction of the
DNA molecule with ligands, especially (but not exclu-
sively) histone proteins. Furthermore, from molecular
biology it is known that other important intracellular
processes such as cell division and protein binding also
depend on the DNA topology, which in turn, depends
on the mechanical properties of the DNA molecule8,9.
DNA topology can be strategically changed during these
processes by the action of enzymes such as the topoiso-
merases, allowing their occurrence efficiently9,10.
Like the proteins and enzymes exemplified above,
many drugs are capable to interact with DNA, modify-
ing its mechanical properties with biological implications
in vivo. Cancer chemotherapy, for instance, is a field
in which the details about DNA interactions with drugs
are important. In fact, some classes of drugs such as
the anthracyclines and the platinum-based compounds
exhibit a strong affinity to interact with the DNA of can-
cer cells. When these drugs bind to DNA they can in-
hibit the replication process, thus stopping the tumor
growth11,12. On the other hand, gene therapy is another
field of medical sciences in which this kind of knowledge
is also important13,14. In these therapies, DNA molecules
are usually transported from outside to inside living cells
in order to replace defective genes, thus correcting cell
malfunctions. One approach to accomplish this transport
easily, for example, is condensing the DNA molecule by
using cationic ligands15,16.
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In summary, all the examples discussed above show
the importance in studying and understanding the details
behind DNA interactions with ligands. In fact, many
researchers of varied areas such as physics, chemistry,
biology, medicine, pharmacy, engineering, etc have paid
attention to this topic along the past 20 years, with a fast
increase of the number of publications and citations17.
In this manuscript we review important topics of the
field “DNA-ligand interactions”, emphasizing in how one
can connect the changes of the mechanical properties of
the DNA induced by the binding ligand to the physic-
ochemical information of such interaction. This type of
connection is interesting because it allows one to perform
a robust characterization of the interaction both from the
mechanical and physicochemical point of view by using
only one experimental technique: single molecule stretch-
ing experiments. To discuss such connection, firstly in
Section 2 we discuss the basic DNA mechanics, revisit-
ing the main concepts and approaches used in the field.
In particular, we revisit the Worm-Like Chain (WLC)
model, the standard one used to describe bare DNA me-
chanics and to investigate the changes of the DNA me-
chanical properties when interacting with a binding lig-
and. Then, in Section 3 we discuss the physical chem-
istry of DNA-ligand interactions, emphasizing the chem-
ical equilibrium states which can usually be described by
a binding isotherm. We revisit the most important mod-
els used in the field, discussing their strong points and
limitations. In Section 4 we discuss briefly the experi-
mental techniques most used to perform single molecule
experiments, emphasizing the key features of each one.
In Section 5 we present and discuss the main types of in-
teractions that occur between DNA and ligands: interca-
lation, covalent binding, electrostatic driven interactions
and groove binding. Finally, in Section 6 we present and
discuss the main topic of this review: the approaches on
how one can connect mechanics to physical chemistry.
The final conclusions are presented in Section 7.
II. DNA MECHANICS
During the last decades, DNA mechanics has become
a very well studied topic especially due to the advent of
single molecule techniques. Such techniques allow one to
manipulate and stretch individual DNA molecules, giving
access to mechanical information contained in the “force
× extension” curves. Before single molecule techniques,
such type of information was somewhat difficult to be
accessed by ensemble-averaging techniques.
From the mid-90s some theoretical models were formu-
lated in order to explain the mechanical behavior of DNA
molecules. In particular, most of these models attempt to
give a theoretical expression for the “force × extension”
curve based on key mechanical parameters such as the
linear contour length of the polymer chain and the DNA
bending stiffness, which can be conveniently represented
by its persistence length.
The contour length is the most basic mechanical prop-
erty of a polymer chain: it is simply the length of the
chain measured along its contour, which is proportional
to the number of monomers. The persistence length, oth-
erwise, is the correlation length of the polymer chain and
thus gives information about the bending stiffness of the
polymer. In the case of DNA molecule, the persistence
length has basically two components: the intrinsic and
the electrostatic one. The first component is related to
the bending rigidity due to the molecule composition it-
self, while the second one is due to the negative charge
distribution along the double-helix18–21. Since these two
components are usually present in most relevant situa-
tions, the models in general represent the persistence
length by its effective value, which takes into account
the two contributions. Following most authors, in this
manuscript we will call the effective persistence length
only by persistence length. In water-based solutions un-
der nearly physiological conditions (pH = 7.4, [NaCl] =
150 mM), a disperse bare DNA molecule is classified as a
semi-flexible (or semi-rigid) polymer due to its interme-
diate value of the bending stiffness, which corresponds to
a persistence length A ≃ 50 nm6,22–24.
In the following section we present the most relevant
model used for studying the mechanics of DNA molecule:
the Worm-Like Chain (WLC) model. In this manuscript
we do not intend to review other mechanical models or
present an historical survey on this specific subject, since
today the WLC model is recognized as the standard one
to study DNA mechanics.
A. Worm-Like Chain Model (WLC)
The Worm-Like Chain (WLC) is a model derived from
polymer physics, and has become in the past years the
standard one in analyzing DNA stretching experiments.
To introduce this model, let us firstly assume that the
polymer itself is a chain formed by rigid rods with lengths
b, connected by freely-rotating vertices. Let us call θi the
angle between the rods i and i + 1. The WLC model
is then defined by assigning an harmonic bending energy
function to the angle formed between the two rods4,24–28,
E(θi) =
κ
2b
θ2i , (1)
taking the continuum limit with b → 0. The constant κ
is the effective elastic bending stiffness of the chain.
In the continuum limit, Eq. 1 can be used to write the
total bending energy of the chain4,24,
E =
κ
2
∫ L
0
|C|2ds, (2)
where C is the local curvature at each point, ds is a length
element along the polymer, and L is the contour length
of the polymer chain.
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The parameter κ is directly related to the polymer per-
sistence length A by
A =
κ
kBT
, (3)
where kB is Boltzmann’s constant and T is the absolute
temperature.
Equation 2 can be used to deduce the behavior of
the force as a function of the polymer extension as one
stretches it. This analysis can be performed numerically
or analytically using appropriate approximations24. In
1995, Marko and Siggia solved the model analytically,
obtaining an approximate expression for the force as a
function of the polymer extension which has become the
most used to analyze DNA stretching experiments in the
entropic low-force regime (F ≤ 5 pN)4,23. Their result is
F =
kBT
A
[
z
L
+
1
4
(
1− zL
)2 − 14
]
, (4)
where F is the force and z is the end-to-end distance
(extension) of the DNA molecule.
Despite its renowned utility, this expression is still an
approximation, diverging at z = L. Moreover, Eq. 4
describes well only the entropic regime of the polymer,
which is valid for stretching forces typically below ∼ 5
pN. In this regime the applied forces are sufficiently small
such that they can change only the polymer conformation
in solution, i. e., its entropy.
Also in 1995, Odjik proposed a different approach that
accounts for higher forces, in which enthalpic effects
start to became relevant for the polymer mechanics5.
The enthalpic regime is defined as the regime in which
the stretching forces became large enough to distort the
DNA primary structure and eventually to break chemi-
cal bonds. Such effect can be accounted by introducing
an enthalpic mechanical parameter to describe the poly-
mer deformation: the stretch modulus S. The analytical
expression proposed by Odjik reads5
z = L
[
1−
1
2
√
kBT
AF
+
F
S
]
. (5)
Observe that the stretch modulus S has units of force.
Taking the limit S → ∞ and inverting the above equa-
tion (isolating F ), we found an equation similar to the
Marko-Siggia expression (Eq. 4) if z ∼ L, i. e., neglect-
ing very small forces. Thus, observe that a polymer in
the entropic regime can be interpreted as a polymer that
has a stretch modulus S very large, i. e., that resists
deformations on its chemical structure.
In 1999, Bouchiat et al. proposed another solution of
the WLC model in the entropic regime. Their approach
consists in adding six terms to Eq. 4 in order to improve
its accuracy29. These terms were determined by com-
paring the results predicted by Eq. 4 to results from an
exact numerical solution of the WLC model29, which was
done perturbatively. The resulting expression reads
F =
kBT
A
[
z
L
+
1
4
(
1− zL
)2 − 14 +
7∑
i=2
ai
( z
L
)i]
, (6)
where the ai’s are constants numerically determined.
In addition to the models discussed above, important
contributions to the elucidation of many peculiarities of
DNA mechanics were given by the groups of A. Volo-
godskii, M. D. Frank-Kamenetskii, H. E. Gaub, M. C.
Williams, V. Croquette, F. Ritort, C. Bustamante and
others, especially concerning the bending of small DNA
fragments, strong bending and fluctuations in the double-
helix, dependence of DNA rigidity on the temperature
and base sequence, DNA twist, overstretching transition,
DNA hairpins, etc.21,22,28,30–51.
III. PHYSICAL CHEMISTRY OF DNA-LIGAND
INTERACTIONS
The study of the physical chemistry of DNA-ligand in-
teractions consists in two different sub-fields: the chemi-
cal equilibrium of the interaction and the kinetics of the
interaction. Consider the system of interest (DNA + lig-
and molecules in solution) as composed by two different
partitions where the ligand molecules can stay: the DNA
(bound ligand molecules) and the solution (free ligand
molecules). The chemical equilibrium is achieved when
the average number of molecules in the partitions remains
constant in time. The kinetics of the interaction, other-
wise, describes the changes that occur between the initial
incubation and the final equilibrium state.
In this manuscript we emphasize the physical chem-
istry of the chemical equilibrium, since the equilibrium
states can be represented by a binding isotherm that can
be linked to the changes of the mechanical properties
of DNA-ligand complexes. Below we discuss the most
relevant models that attempt to describe the chemical
equilibrium of DNA-ligand interactions. Some studies on
the kinetics of such interactions were performed by the
groups of M. C. Williams, D. Anselmetti, D. M. Crothers
and others52–60.
A. The general problem
Consider two molecules A and B associating in solu-
tion to result in a molecule C. This mechanism can be
represented by the chemical reaction
A+B
Ki
⇋
Kd
C, (7)
where Ki and Kd are, respectively, the equilibrium in-
trinsic binding constants of association and dissociation.
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They are also known as thermodynamic constants or
macroscopic constants. Observe that Ki represents the
association reaction, where the reagents A and B asso-
ciate to result in the compound C, while Kd represents
the dissociation reaction, i. e., the reverse reaction in
which C dissociate in the original reagents A and B.
These constants are defined in term of the molar con-
centrations of the involved substances,
Ki =
[C]
[A][B]
, (8)
and
Kd =
[A][B]
[C]
= K−1i . (9)
Note that in these last two equations, [X ] is the molar
concentration (1 M = 1 mol/liter) of the compound X .
Also observe that Ki has units of M
−1, while Kd has
units of M.
B. Scatchard model
This is the simplest model that describes the chemical
equilibrium of the DNA molecule with ligands in solu-
tion. Let us firstly adapt the previous notation for the
specific case of DNA-ligand interactions. Call [A] ≡ Cf
the concentration of free ligands solution and [C] ≡ Cb
the concentration of ligands bound to DNA (result of
the reaction). Suppose firstly that each ligand molecule
occupies only one base pair of the DNA when bound.
Consequently, the concentration of free linkable sites in
the DNA molecule can be written as [B] ≡ Cbp - Cb,
where Cbp is the concentration of DNA base pairs, which
is a constant.
Substituting these definitions in Eq. 8, one has
Ki =
Cb
Cf (Cbp − Cb)
. (10)
Now we introduce the bound ligand fraction r,
r =
Cb
Cbp
, (11)
such that Eq. 10 can be rewritten as
r =
KiCf
1 +KiCf
, (12)
which is known as the Scatchard binding isotherm, pro-
posed originally in 194961.
Despite its didactic utility, the Scatchard binding
isotherm has two important simplifications: (a) It is valid
only for very small ligand molecules which occupy only
one DNA base-pair when bound, which is not the case
for most ligand molecules. (b) It supposes that previous
bound ligand molecules do not interfere in the binding
mechanism of the subsequent ones, i. e., the interaction
is non-cooperative.
The first simplification can be bypassed by introducing
the parameter rmax, the bound ligand fraction at satura-
tion, i. e. the maximum value of the bound ligand frac-
tion r. Observe that the inverse of rmax is the mean num-
ber of base pairs occupied by each bound ligand molecule
N = 1/rmax. The corrected binding isotherm then reads
r =
rmaxKiCf
1 +KiCf
, (13)
C. Hill model
The Hill binding isotherm was originally proposed by
A. V. Hill in 1910 to describe the binding of oxygen to
hemoglobin inside red blood cells62.
Basically the model introduces the Hill exponent n, a
cooperativity parameter which is a lower bound for the
number of cooperating ligand molecules involved in the
reaction63,64. The binding isotherm reads
r =
rmax(KiCf )
n
1 + (KiCf )n
. (14)
The apparent binding association constant of the re-
action is defined as KA = K
n
i . Observe that if n > 1,
the interaction is positively cooperative, i. e., a bound
ligand molecule increases the apparent affinity of DNA
for subsequent ligand binding. If n < 1, otherwise, the
interaction is negatively cooperative and a bound ligand
molecule decreases the apparent affinity of DNA for sub-
sequent ligand binding. If n = 1, the interaction is non-
cooperative and the affinity is independent of the number
of previously bound ligand molecules.
The Hill binding isotherm has achieved a particu-
lar success to describe positively cooperative “none-or-
all” processes (n > 1), in which the cooperating ligand
molecules bound practically simultaneously to the bound
site forming a bound cluster63,65. On the other hand,
when n = 1 the Hill isotherm reduces to the Scatchard
one and is therefore able to describe individual binding
of ligand molecules64. Finally, to the best of our knowl-
edge there is no report in the literature of a negatively
cooperative DNA-ligand interaction described by a Hill
binding isotherm.
D. Neighbor exclusion model (NEM)
This model was proposed in 1974 by McGhee and von
Hippel with the purpose of analyzing in detail the neigh-
bor exclusion effects due to large ligand molecules that
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occupy more than one DNA base-pair66,67. The authors
have accounted for the ligand size by introducing the ex-
clusion parameter N , the number of base-pairs that a lig-
and molecule effectively occupies when binding to DNA.
This parameter was cited earlier in connection to the sat-
urated bound ligand fraction, N = 1/rmax.
The model has a non-cooperative and a cooperative
version, but the last one has been used only in a few
works68,69 to analyze experimental data because the
binding isotherm is somewhat intricate.
The non-cooperative binding isotherm reads
r
Cf
= Ki(1−Nr)
[
1−Nr
1− (N − 1)r
]N−1
, (15)
and the cooperative binding isotherm reads
r
Cf
= Ki(1−Nr)
[
(2ω − 1)(1−Nr) + r −R
2(ω − 1)(1−Nr)
]N−1
×
[
1− (N + 1)r +R
2(1−Nr)
]2
,(16)
with
R =
√
[1− (N + 1)r]2 + 4ωr(1−Nr). (17)
Here ω is the cooperativity parameter. For ω smaller,
equal, or larger than unity, one has negative, non-
cooperative, or positive cooperativity, respectively.
The major advantage of this model is to treat in more
detail the effects related to the ligand size. This feature
is particularly important in the analysis of DNA inter-
actions with intercalators, a class of ligands in which
neighbor-exclusion effects is extremely important70–72.
In fact, NEM has become in the past years the stan-
dard binding isotherm used to analyze DNA interactions
with intercalators73–77.
IV. SINGLE MOLECULE EXPERIMENTAL METHODS
In this section we briefly discuss the single molecule
experimental techniques commonly used to measure the
mechanical properties of the DNA-ligand complexes.
The main advantage of single molecule techniques is
the possibility to study a particular DNA molecule free
from the influence of other molecules in the sample. Sin-
gle molecule stretching experiments such as those per-
formed with optical or magnetic tweezers usually give in-
sights on the global (long length scale) mechanical prop-
erties of individual DNA molecules. In fact, mechanical
parameters such as the persistence and contour lengths
and the stretch modulus can be extracted by analyzing
the force × extension curves of the complexes, which can
be obtained in single molecule approaches.
Useful reviews which discuss and compare single
molecule techniques can be found in the literature78–80.
A. Optical tweezers
Since the seminal works of Ashkin and
collaborators81,82, optical trapping and manipula-
tion have found various applications in many areas of
science such as physics, biology and chemistry. Today,
the most common optical tweezers are mounted by
focusing a laser beam with a microscope objective of
large numerical aperture. This apparatus can trap small
dielectric objects near the lens focus, being a powerful
tool to manipulate beads, particles and biological
systems with typical sizes in the micrometer range82,83.
The typical forces obtained with this apparatus are
between 0.1 - 400 piconewtons, which are in the range of
many biological forces such as the entropic and enthalpic
forces on biopolymers and molecular motors. For an
introductory review about the basic theory and features
of optical tweezers, see ref.84. Other useful reviews on
instrumentation and recent advances on the technique
can also be found in the literature85–88.
To perform precise quantitative measurements with
optical tweezers, size-calibrated dielectric beads have be-
come the standard objects to be captured because of their
perfect symmetry which facilitates trap calibration and
position detection. A dielectric bead trapped in an opti-
cal tweezers is an overdamped Brownian harmonic oscil-
lator, such that the optical trap can be characterized by
its trap stiffness κ which depends on the bead size and
refractive index84.
In the last decades, optical tweezers have been largely
used to study the mechanical properties of DNA/RNA
molecules and their complexes formed with drugs or
proteins. Useful reviews on this subject can be found
in the literature89–92. Basically, the classic experiment
consists in attaching one end of the DNA molecule
to a polystyrene or silica bead and the other end to
a substrate (a microscope coverslip or a second bead
attached to a micropipette, for example). The opti-
cal tweezers is then used to trap the bead and so the
DNA molecule can be manipulated and stretched by
moving the laser beam or the microscope stage. The
force as a function of extension can be measured as one
stretches the DNA molecule. To perform this task, one
needs to detect the bead position and to calibrate the
tweezers (determine the trap stiffness κ). There are
many techniques which can be used to perform this kind
of measurement, such as dynamic light scattering93,94,
back-focal plane interferometry95, statistics of thermal
fluctuations96, simple videomicroscopy64,97,98, calibra-
tion using hydrodynamic drag forces56 or by using other
types of detectors91. For a recent review on measuring
with optical tweezers, see ref.85.
Figure 1 shows a typical force × extension curve of a
single bare λ-DNA molecule (∼ 48,500 base-pairs) ob-
tained by performing a DNA stretching experiment in
the entropic regime with optical tweezers. The trap cali-
bration and the bead position detection were performed
in this case by using videomicroscopy97, and the solid
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FIG. 1. Force × extension curve of a bare λ-DNA molecule
in the entropic regime. Circles: experimental data obtained
with optical tweezers; Solid line: a fitting to the Marko-Siggia
Worm-Like Chain (WLC) model (Eq. 4). For this particular
DNA molecule we have found from the fitting A = (50 ± 2)
nm and L = (15.6 ± 0.1) µm.
line corresponds to a fitting using the Marko-Siggia WLC
model (Eq. 4). From the fitting one can promptly de-
termine the persistence and contour lengths of the DNA
molecule, obtaining for this particular curve A = (50 ±
2) nm and L = (15.6 ± 0.1) µm.
B. Magnetic tweezers
The idea behind magnetic tweezers is very similar to
its optical analogue, the main difference is that in this
case the forces are exerted by an external magnetic field
applied around the sample. Paramagnetic beads are used
instead of dielectric ones in order to be manipulated with
the magnetic field. The typical forces obtained are of
the order of hundredths of piconewtons to hundreds of
piconewtons.
Basically, the force applied on the paramagnetic beads
can be written as
−→
F = −
1
2
−→
∇(−→µ ·
−→
B ), (18)
where −→µ is the magnetic dipole moment induced in the
bead and
−→
B is the applied magnetic field. Observe that
for moderate magnetic fields one has −→µ ∝
−→
B and the
resulting force is proportional to the gradient of the field
intensity.
Reviews on the basic and advanced features of mag-
netic tweezers can be found in the literature99–101.
An advantage of this technique in relation to opti-
cal tweezers is its convenience to apply torques on the
magnetic beads by rotating the external magnetic field,
which allows one to rotate DNA molecules and therefore
to study quantities such as the torsional rigidity and the
degree of supercoiling22,39,50,102–105. These quantities are
also mechanical properties important to some biological
processes in which the double-helix must be unwound,
such as in DNA replication. Another advantage of the
magnetic tweezers is its convenience to perform constant-
force experiments, working as a force-clamp trap (it is
just a matter of choosing the adequate magnetic field -
see Eq. 18). Constant-force experiments can be per-
formed with optical tweezers only using non-conventional
(and more intricate) approaches such as by using a force-
feedback electronics or working in anharmonic regions of
the optical potential106,107. Among the disadvantages of
using magnetic tweezers, one can cite the hysteresis of
the magnetic field and heat generation around the sam-
ple if the field is produced by current distributions, aside
the more intricate calibration of the apparatus and its
restriction to applications with magnetic materials. A
recent work by Neuman and Nagy provides a detailed
comparison between optical and magnetic tweezers, and
also atomic force microscopy79.
C. Atomic force microscopy (AFM)
Atomic force microscopy (AFM) is another impor-
tant tool in single-molecule studies of DNA-ligand
interactions108,109. In the last 20 years, a number of dif-
ferent protocols have been developed in order to deposit
DNA molecules on a flat surface and to image them reli-
ably and reproducibly. Today, the standard surfaces used
to deposit the DNA molecules are mica substrates and
less often silicon substrates, because of their low rugosity.
A number of buffer solutions containing divalent cations
(such as Mg2+, Ni2+, Mn2+, Co2+ and Ca2+) have been
used to enhance the DNA adsorption onto the substrate,
which is otherwise poor. Moreover, divalent cations also
allow the polymer chain to equilibrate on the flat 2D ad-
sorbing surface, preventing chain kinetic trapping, which
must be avoided in order to study equilibrium proper-
ties of the adsorbed DNA or DNA-ligand complex108.
Once adsorbed, DNA molecules and DNA-ligand com-
plexes can be imaged using the AFM usually operating
in the tapping mode, which minimizes possible damages
to the sample due to the tip-surface interactions during
the scanning. The images obtained are topographical
maps which associate a certain height to each point on
the sample. By analyzing these images, several DNA
statistical parameters such as the mean contour length,
the persistence length and bending angles can be esti-
mated. As discussed by Rivetti et al.110, this analysis
can be performed, for example, by measuring the mean-
squared end-to-end distance < R2 > of the polymer. In
fact, statistical mechanics of polymers predicts that for
2D worm-like chains (which is the case of deposited DNA
molecules), < R2 > is given by
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< R2 >= 4AL
[
1−
2A
L
(
1− e−
L
2A
)]
. (19)
By using this equation it is possible determine the per-
sistence length A by measuring < R2 > and the contour
length L for the deposited DNA molecules.
On the other hand, the visualization of DNA conden-
sates formed with polycations with the AFM technique is
nowadays a routine in many laboratories. The morphol-
ogy of these condensed DNA complexes seen in the AFM
images are as well as clear and well-defined as the images
produced by other kinds of microscopy techniques such as
electron microscopy (EM). The structure of DNA-protein
complexes has also been a target of a number of stud-
ies. Within the limits of the AFM technique are, for
instance, the visualization of sharp kinks and cross-links
introduced in the DNA molecule by histone-like proteins,
the structure of nucleosome particles, the determination
of protein binding-sites and more recently the determi-
nation of protein association constants to DNA111.
Finally, besides being a powerful tool for visualizing
single molecules, the AFM apparatus can also be used
to perform force spectroscopy in solution like optical or
magnetic tweezers, allowing one to determine the force ×
extension curves of the DNA-ligand complexes36,112,113.
Specific reviews about the application of the AFM
technique to single molecule studies can be found in the
literature113,114.
As a final remark, with the improvement of fluorescent-
based optical technology along the last decades, fluores-
cence microscopy has also became another important tool
to visualize DNA structure, conformation changes and
interactions with ligands at single molecule level115–123.
The technique can be used as complementary to AFM,
with the advantage that one does not need to deposit the
molecules in a substrate.
V. DNA-LIGAND INTERACTIONS
DNA can interact with ligands in many different ways,
from covalent binding to simple electrostatic driven inter-
actions. Here we describe briefly the most relevant types
of interactions, discussing the main features of each one.
A. Covalent ligands
The covalent binding of drugs to DNA is usually ir-
reversible and completely inhibit DNA processes. The
platinum-based compounds are examples of drugs which
can interact with DNA by covalent binding124,125. Cis-
platin and its related compounds carboplatin and ox-
aliplatin are antitumor platinum-based molecules usu-
ally used in cancer chemotherapy. The action of these
complexes as anticancer drugs consists in damaging the
DNA molecule with adducts that form various types of
crosslinks, which introduce strong structural perturba-
tions and impede DNA replication126,127. The clinical
use of these complexes, however, is limited due to their
several side effects and the development of drug resis-
tance.
Another example of covalent binding is found in the
interaction of drugs from the class of furocoumarins (pso-
ralen, angelicin, etc) with DNA when one illuminates
the complex with ultraviolet-A (UVA) light128. Pso-
ralen is a well-known drug used in the treatment of skin
diseases like psoriasis, vitiligo, and some other kinds of
dermatitis129. The most common therapy is called PUVA
(psoralen followed by UVA light), which consists in tak-
ing a medicine containing psoralen and exposing the pa-
tient to UVA light. The drug effectively increases the
skin sensitivity to UVA and the skin melanin level130,131.
It is well established in the literature that when a DNA-
psoralen complex is illuminated with UVA light, the drug
molecules absorb photons and form covalent bonds pref-
erentially with the thymines128,132. When there is no illu-
mination at the sample, however, psoralen interacts with
DNA by intercalative binding - see next section. The ef-
fects of covalent binding on the mechanical properties of
the DNA-psoralen complexes were recently studied94,133.
In particular, it was shown that the contour and persis-
tence lengths of the complexes depend on the psoralen
concentration and on the exposure time to UVA light133.
B. Intercalators
Intercalative binding is one of the most common in-
teractions between DNA and ligands, and was firstly de-
scribed by L. S. Lerman in 1961134,135. It is characterized
by the insertion of a flat aromatic molecule between two
adjacent DNA base pairs. The complex is thought to be
stabilized by the stacking interactions between the lig-
and and the DNA bases136. Intercalators also introduce
strong structural perturbations on the double-helix struc-
ture. To accommodate the intercalated molecules, there
is an increase in the DNA contour length, which is ac-
companied by an unwinding of the double-helix by a cer-
tain angle per intercalated molecule56,70–73,137. Dauno-
mycin, doxorubicin and ethidium bromide (EtBr) are
classic examples of drugs which intercalate in the DNA
molecule and can modify its elasticity depending on the
drug concentration. Daunomycin and doxorubicin are
anthracycline antibiotics used in the treatment of vari-
ous cancers such as some types of leukemias, sarcomas,
lymphomas, myelomas, neuroblastomas, as well as can-
cers in the breast, head, ovary, pancreas, prostate, stom-
ach, liver, lung and others. They inhibit DNA replica-
tion and transcription when intercalating, impeding cell
duplication73. Ethidium bromide (EtBr) is commonly
used as a fluorescent stain for identifying and visualizing
nucleic acid bands in electrophoresis and in other meth-
ods of nucleic acid separation. Other known intercalators
are the DNA fluorescent stains acridine orange, methy-
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lene blue138 and diaminobenzidine76. More examples and
specific reviews on the basic properties of intercalators
can be found in the literature70–72.
Many aspects of the DNA-daunomycin interaction,
such as kinetics, self association and equilibrium bind-
ing were studied by J. B. Chaires, D. M. Crothers and
coworkers in the 80’s60,73,137,139. On the other hand, the
DNA-EtBr interaction was characterized in various as-
pects by many authors, but even today one can found
somewhat contradictory results about the mechanical be-
havior of such complexes23,56,75,77,140–142, and also for
different complexes formed between DNA and other in-
tercalators, especially when comparing results obtained
from different experimental techniques56,75–77,115,140–146.
Recently our group has studied in detail the changes
in the persistence and contour lengths of DNA complexes
formed with various intercalating molecules75–77,94,133,
by using optical tweezers in a very low force regime (F <
2 pN). We reported an abrupt structural transition in
the persistence length due to drug intercalation, which is
probably related to a partial denaturation of the DNA
molecule due to the pulling force used to stretch the
complexes76,77,133,147. The contour length, otherwise,
does not present such a transition, increasing monotoni-
cally with drug concentration until saturation.
C. Electrostatic driven interactions
Since the DNA molecule has a high negative charge
density in aqueous solution due to its phosphates (2 el-
ementary charges per each 3.4 A˚ along the DNA axis),
it strongly interacts with itself (i. e., different DNA seg-
ments strongly repel each other thus promoting the chain
swell) as well as with positively charged ligands such as
ions and macro-ions, especially multivalent cations148.
DNA condensation due to multivalent cations is a clas-
sic example which shows the importance of electrostatic
driven interactions in DNA solutions148–151. In this pro-
cess the multivalent cations binds along the DNA double-
helix, and the strong positional correlations between
them start to play a role and promotes a coil-globule
transition: the DNA molecule folds onto itself152–154 with
a high increase in the local DNA segment density at
the level of both mono-molecular collapse or in a multi-
molecular aggregation.
Some models concerning electrostatic interactions be-
tween DNA and ligands were proposed along the last
decades19,155,156. In fact, there are different hypotheses
to explain the DNA bending mechanism by multivalent
cations, including a purely electrostatic model by Rouz-
ina and Bloomfield155 and an asymmetrical phosphate
neutralization model by Manning19. According to Rouz-
ina and Bloomfield, a multivalent cation binds to the en-
trance of the DNA major groove, between the two phos-
phate strands, electrostatically repelling sodium counte-
rions from the neighboring phosphates. The unscreened
phosphates on both strands are strongly attracted to the
groove-bound cation. This binding leads to groove clo-
sure, accompanied by DNA bending towards the cationic
ligand155. Differently, Manning proposes that the sta-
ble double-helix structure of DNA represents an equi-
librium between stretching forces (caused by interphos-
phates repulsion) and compressive forces (caused by at-
tractive interaction between nucleotides). This analysis
suggests that significant local interphosphate stretching
forces balance compressive forces within DNA and that
these stretching forces can drive DNA deformation when
phosphates charge are locally neutralized.
These two approaches predict a reduction of the per-
sistence length as the concentration of bound cations in-
creases. In fact, the model proposed by Rouzina and
Bloomfield predicts that the effective persistence length
AE of the DNA-ligand complex is given by
1
AE
=
1
A1
+
Nr
A2
, (20)
where A1 is the bare DNA persistence length (when no
ligands are bound r = 0) and 1/A1 + 1/A2 is the in-
verse persistence length of a DNA saturated with ligands
(which occurs when r = rmax = 1/N). Observe that
here N is the exclusion parameter of the ligand and r =
Cb/Cbp is the ratio between the bound ligand concentra-
tion and the DNA base-pair concentration, as introduced
in Section III.
The model developed by Manning, on the other hand,
predicts that the effective persistence length AE of the
DNA-ligand complex (charge neutralized DNA) is related
to the original persistence length A0 (fully charged DNA)
by the equation19,156
AE =
2
piR2
[
βA0
2(ξ − 1)− ln(κb)
]3/2
, (21)
whereR is the radius of the double helix, β is the Bjerrum
length (distance between two unit charges in pure solvent
- no other ions - at which the electrostatic energy is kBT ),
1/κ is a measure of the extent of the ion cloud around the
object, b is the average axial distance between phosphates
(0.17 nm) and ξ = β/b is a measure of the axial charge
density of the DNA156.
This model predicts, for example, that for 30% of neu-
tralized charge, the effective persistence length is AE =
33.2 nm. For 60% of neutralized charge, AE = 11.1 nm
and for 100% of neutralized charge, AE = 7 nm
156.
D. Major and minor groove ligands
Most drugs that interact electrostatically with DNA
usually exhibits a preference to the major or minor groove
floor of the double-helix. Many minor groove ligands are
known by their antitumor and antibiotic functions. This
kind of interaction is usually characterized by a com-
bination of electrostatic, van der Waals and hydrogen
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bonds. Examples of minor groove ligands are the anti-
cancer compound distamycin A, the antibiotics netropsin
and berenil, and the fluorescent stain DAPI. These drugs
usually form reversible complexes with DNA, preferen-
tially binding at AT base pairs sequences. They also in-
duce elasticity changes on the DNA molecule, stabilizing
the double-helix structure56. An extensive review on the
DNA minor groove complexes can be found in ref.157.
On the other hand, major groove binding is also a
kind of interaction usually characterized by electrostatic
binding56. α-Helical (Ac-(Leu-Ala-Arg-Leu)3-NH linker)
is a peptide which interacts with DNA via major groove
binding56. Other known examples are the intercalator
and major groove ligand YO158, the bis-intercalator and
major groove ligands YOYO and ditercalinium145,158,159
and the anticancer drug neocarzinostatin159. More ex-
amples and a discussion on the main characteristics of
major groove binding ligand can be found in a recent
review159.
E. Ligands with multiple binding modes
There are many ligands which can interact to DNA by
different binding modes, depending on factors such as the
properties of the surrounding buffer solution, the DNA
base-pair sequence, external conditions such as sample il-
lumination, etc. Some examples were already cited in the
last sections. In some cases the ligand has distinct por-
tions which interact to DNA by different modes. In other
cases there is only a single binding mode for the entire
ligand molecule, which can be changed upon determined
conditions.
Bis-intercalators like YOYO and ditercalinium, for in-
stance, are molecules which have two intercalating por-
tions linked by another chemical structure which some-
times may interact with the DNA grooves145,158,159.
Actinomycin D is another example of a drug with
distinct portions that interact to DNA by different
modes, in this case including minor groove binding and
intercalation64,160–163.
Psoralen is an example of a drug which the binding
mode depends on an external condition (sample illumina-
tion). As explained before, the drug initially intercalates
in DNA, but forms covalent bonds with the thymines if
the sample is illuminated with UVA light.
Hoechst 33258 is a fluorescent stain that can bind to
DNA by intercalation or groove binding, with two dif-
ferent sets of physicochemical parameters. In this case
the drug concentration is the factor that determines the
dominant binding mode65. Some authors report a similar
behavior for the intercalator doxorubicin, have founding
a possibility of groove binding at AT-rich regions164.
VI. CONNECTING MECHANICS TO PHYSICAL
CHEMISTRY
In this section we introduce the main subject of this re-
view, the approaches developed to establish connections
between the mechanical properties and physicochemical
properties of DNA-ligand complexes. As stated before,
the advantage in establishing this type of connection is
the possibility to deduce one or more properties of a
certain type (physicochemical properties, for example)
knowing only the behavior of a property of the other
type (the persistence or contour length, for example).
With such connection(s), one can considerably reduce
the number of different experimental techniques neces-
sary to perform a robust characterization of the DNA
interaction(s) with a certain type of ligand. This fact
thus reduces the time and cost required for getting data,
since less different equipments are needed and the num-
ber of experiments that must be conducted can be con-
siderably reduced. Furthermore, and perhaps more im-
portant, the approach opens the possibility of comparing
data obtained by means of very different experimental
techniques, increasing confidence in the results.
In single molecule stretching experiments performed by
optical or magnetic tweezers, the typical result obtained
is the force× extension curve of the molecule, from where
the mechanical properties can be extracted by fitting an
appropriate model (for DNA, the WLC model). We will
show that if one knows how the contour and/or the per-
sistence length varies as a function of the total concen-
tration of ligand in solution (CT ) (which is the amount
of ligand added in sample preparation), it is possible to
deduce physicochemical properties such as the equilib-
rium constants, the cooperativity degree, the exclusion
number, etc.
A. Historical survey
Along the past years many groups have used
single molecule techniques to identify the pos-
sible binding mechanisms of DNA-ligand inter-
actions and to extract physicochemical infor-
mation of such interactions from these types of
experiments56,63,65,75,90–92,97,98,137,140,158,165–172.
To the best of our knowledge, the first attempt to
connect mechanics to physical chemistry for DNA-ligand
systems was performed in the early 80’s by the group
of D. M. Crothers, who have measured the changes of
the DNA contour length when interacting with various
drugs (netropsin, distamycin, iremycin, daunomycin) as
a function of the bound ligand fraction r, by using electric
dichroism and a phase partition technique137,165. Never-
theless, they have not directly determined physicochem-
ical properties from such data, a task which could only
be performed with complementary analyzes and/or tech-
niques.
In 1996 Coury et al.166 has determined physicochemi-
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cal properties from the contour length data of some DNA-
ligand complexes, obtained using AFM166. In fact, by
determining the relative increase of the contour length of
DNA complexes formed with intercalators such as dauno-
mycin and ethidium bromide, the authors were capable
to estimate binding parameters such as the equilibrium
constant and the exclusion number. Similar approaches
were used by Mihailovic et al.167 and Rocha et al.75 to
extract physicochemical information of DNA-intercalator
complexes by measuring the relative increase of the con-
tour length, obtained using optical tweezers.
Basically, the idea to perform such task is the following.
Call ∆ the natural distance between two DNA base pairs,
which is ∼ 0.34 nm for B-DNA. When an intercalating
molecule binds to this site, it increases such distance to a
new value ∆ + δ. Call L0 the bare DNA contour length
and L the new length for a certain amount of bound
ligand represented by the bound fraction r. One can
promptly write the relation
L = L0 +Nbδ, (22)
where Nb is the number of bound ligand molecules.
Observe that L0 = Nbp∆, being Nbp the number of
DNA base-pairs. Therefore one can write the relative
change of the contour length Θ as
Θ =
L− L0
L0
=
Nbδ
Nbp∆
= γr, (23)
where γ = δ/∆.
With Eq. 23 one can directly connect the mechanical
parameter L to physicochemical parameters by express-
ing the bound ligand fraction r by an adequate binding
isotherm. In the case of intercalators, the more conve-
nient binding isotherm is the Neighbor Exclusion Model
(NEM) (see Section IIID), since this isotherm captures in
detail the neighbor exclusion effects which always follow
intercalative binding. Nevertheless, there are two prob-
lems that must be bypassed to use this approach. The
first one is that in the NEM binding isotherm one can-
not analytically isolate the parameter r to substitute in
Eq. 23. This problem, however, can be bypassed with
numerical approaches, as will be discussed soon. The
second and more serious problem is that, not only NEM,
but all binding isotherms are written as functions of the
free ligand concentration Cf , which is not a directly ac-
cessible parameter. In fact, in general one knows only
the total ligand concentration in solution CT , the quan-
tity used to prepare the sample, which is the sum of the
bound and free ligand concentrations, i. e.,
CT = Cf + Cb. (24)
The partitioning of CT into Cf and Cb is not trivial to
be measured and one usually needs other experimental
techniques (microcalorimetry, absorption spectroscopy,
equilibrium dialysis, etc.) to evaluate such partitioning.
There are, however, approaches that can be performed
to bypass this problem, allowing one to use only single
molecule stretching to characterize the interaction. In
fact, one can estimate the bound ligand concentration
from contour length changes if the length increase due to
a single binding event (δ) is known166,167. Alternatively,
as a first-order approximation one can consider Cf ∼
CT in the binding isotherm if the DNA concentration
in the sample is very low (because Cb will also be very
low in this case)63,167. This approximation is much used
in typical tweezers experiments that tether an individual
DNA molecule and then rinse away any DNA molecules
in solution prior to the introduction of a ligand. Such
approach is convenient because it allows one to express
the binding isotherm as a function of a directly accessible
parameter (CT ), although it cannot be used always. A
different approach was proposed originally by Rocha et
al. in 200775, which consists in manipulating Eqs. 24, 23
and 15 to write the relation
CT =
Cbp
γ
Θ+
Θ(γ − nΘ+Θ)n−1
Ki(γ − nΘ)n
. (25)
Such approach allows one to directly fit the contour
length data without any approximation: one should just
plot the total ligand concentration CT in the y-axis and
the relative increase of the contour length Θ in the x-axis,
such that Eq. 25 can used directly to fit the experimental
data. In Fig. 2 we show an example of such fitting,
performed originally in ref.76 for DNA complexes formed
with the intercalator diaminobenzidine. Other examples
can be found in refs.75 and133 for DNA complexes formed
with the intercalators ethidium bromide and psoralen,
respectively.
One should note, however, that the contour length ap-
proaches discussed above can only be used for intercala-
tors. In fact, only intercalators increase the DNA con-
tour length when binding56,73,137. An exception are lig-
ands that facilitate or inhibit base pair formation, which
can also be studied by contour length approaches simi-
lar to those discussed above, using length changes as a
marker of ligand binding173. The other common types
of interactions between DNA and ligands, such as groove
binding, electrostatic interaction or covalent binding in
general do not affect the DNA contour length. In some
cases, however, these kinds of interactions can cause DNA
compaction with a decrease of the “apparent contour
length” measured by force spectroscopy in the low-force
regime65,97,98. The concept of “apparent contour length”
arises from the fact that, if the DNA molecule is partially
compacted due to ligand binding, small forces in the en-
tropic regime usually are not sufficient to fully stretch
the molecule, and therefore the measured contour length
will be smaller than the real one. Depending on the
type of interaction, even high forces cannot be used to
fully stretch the complexes and estimate the real contour
length by fitting the WLC model174. The decrease of the
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FIG. 2. Experimental result (circles) of CT × Θ mesured for
DNA complexes formed with the intercalator diaminobenzi-
dine, and a fitting to Eq. 25 (dashed line). Observe that Eq.
25 fits well to the experimental data, returning the values of
the physicochemical parameters N = 2.5 ± 0.6, Ki = (1.8 ±
0.6)×104 M−1 and γ ∼ 1. For this data Cbp = 2.4 µM.
“apparent contour length” upon increasing of the bound
ligand concentration in general depends on intricate ef-
fects such as the positional correlation of bound ligands.
This fact makes it difficult to directly link the contour
length data to a binding isotherm, although other kinds
of analyses can be performed to study such interactions.
On the other hand, the other basic mechanical
property (the persistence length) is much more sen-
sitive to other types of interactions, and in gen-
eral changes for covalent binding97,98,126,133, intercala-
tive binding56,75–77,103,140,141 and groove/electrostatic
binding19,56,64,65,91,92,155. This fact turns the persis-
tence length into the ideal mechanical property to be
choosen for monitoring DNA-ligand interactions and to
be connected with the physical chemistry of such inter-
actions. Nevertheless, such connection is not straight-
forward as the one performed for the contour length of
DNA-intercalator complexes.
Only in 1998 the first attempt to connect the per-
sistence length to physicochemical properties was per-
formed by Rouzina and Bloomfield155, which can be syn-
thesized in Eq. 20 presented earlier. This model however
was derived in the context of electrostatic interactions
and attempt to explain the changes of the persistence
length due to the negative charge neutralization in the
DNA phosphate backbone155. Recently, this model has
been used to fit experimental data of DNA complexes
formed with positively charged proteins such as HMG,
HMGB1 and HMGB291,92, with excellent agreement.
The question now is: Can the changes of the persis-
tence length be related to physicochemical parameters
for any type of interaction? In the next section we dis-
cuss an approach that can be used to perform such task.
B. A general model to connect the persistence length to
physical chemistry
The DNA molecule partially covered by ligand
molecules along its structure can be thought as an as-
sociation of entropic springs in series. One type of
spring is the bare DNA with its natural persistence
length A0, corresponding to the regions without bound
ligands along the contour length of the molecule. The
other type(s) of spring(s) is(are) the local complexe(s)
formed between DNA and the bound ligand molecules.
A simple phenomenological model to study the persis-
tence length of DNA-ligand complexes that uses this
assumption was proposed by Rocha147. Latter, it was
rigourously demonstrated63 that a series association of
n entropic springs with persistence lengths A0, A1, A2,
..., An−1 results in an effective entropic spring with the
effective persistence length AE given by
1
AE
=
f0(r)
A0
+
f1(r)
A1
+
f2(r)
A2
+ ..., (26)
where f0(r), f1(r), f2(r), etc are specific functions of the
bound ligand fraction r.
The function fi(r) is in fact the probability of finding
an entropic spring (a part of the DNA molecule) along
the contour length with a local persistence length Ai
63,
which depends on the bound site fraction r63,66.
In general, the approach proposed in Eq. 26 can be
applied by following three steps:
(a) One needs firstly to find the probability distribu-
tion of the bound ligands, i. e., the set of functions fi(r).
(b) The second step is to choose an adequate bind-
ing isotherm that captures the physical chemistry of the
system, and then plug such isotherm in Eq. 26 via the
parameter r.
(c) Finally, the third step is to use the equation con-
structed in step (b) to fit the experimental data of the
persistence length, extracting the physicochemical pa-
rameters contained in the binding isotherm and the set
of local persistence lengths Ai’s.
To deduce the probability distribution mentioned in
step (a), the easiest way is firstly identify how many dif-
ferent entropic springs one needs in the model to correct
reproduce the experimental behavior of the persistence
length as a function of ligand concentration. The sim-
plest behavior of this parameter reported in the litera-
ture is a monotonic decay, found for example for the pro-
teins HMG, HMGB1 and HMGB291,92 and for the drug
cisplatin97,98. This relatively simple behavior of the per-
sistence length can be explained with a model consisted
only by two entropic springs, one representing the bare
DNA (local persistence length A0) and the other repre-
senting the local structure formed by the ligand molecule
bound to the DNA (local persistence length A1).
From now on let us consider a “site” the place ef-
fectively occupied by a single ligand molecule (or by a
single bound cluster of molecules, in the cases in which
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the ligands bind to DNA forming clusters due to high
positive cooperativity). One should note that even for
single-ligand binding the sites are usually higher than
one DNA base-pair, due to ligand size and/or neighbor-
exclusion effects. A model with only two different types
of entropic springs, as proposed in the last paragraph, is
a one-site quenched disorder statistical model, since the
probability distribution depends only on the occupancy
of single sites along the double-helix, i. e., it does not
depend on the correlation with the occupancy of nearest
neighbor sites.
Consider now a particular site choose randomly along
the DNA. The probability of this site to be occupied by
a ligand molecule is x = r/rmax, with a local persistence
length A1; and the probability of this site to be unoccu-
pied is 1 - x, with a local persistence length A0
63,66. The
effective persistence length can then be written as
1
AE
=
1− x
A0
+
x
A1
, (27)
and x = r/rmax can be directly connected to a binding
isotherm.
Equation 27 was recently used by Crisafuli et al. to
determine the physicochemical parameters of the DNA-
cisplatin interaction from the persistence length data of
these complexes97,98. One should observe that, since the
exclusion number N is related to the saturated bound
ligand fraction rmax by N = 1/rmax, the electrostatic
model proposed by Rouzina and Bloomfield155 (Eq. 20)
is a particular case of Eq. 27 (it is just a matter of redefin-
ing the physical interpretation of the constants Ai’s).
There are other types of ligands that can induce
a more intricate non-monotonic behavior for the per-
sistence length as a function of the ligand concentra-
tion. Probably the most known example is the bacte-
rial protein HU175, but some drugs such as catinonic
cyclodextrins63, actinomycin D64 and hoechst 3325865
also induce such behavior. To account for the persistence
length changes of the DNA complexes formed with these
compounds, the one-site model discussed above does not
work, and one needs to introduce at least one more en-
tropic spring with other local persistence length (A2),
i. e., one needs a two-sites quenched disorder statisti-
cal model, in which one must consider the probabilities
associated with the occupancy of two nearest sites. In
the context of a two sites model, there are therefore the
following probabilities associated to the local persistence
lengths: (a) two nearest sites unoccupied have local per-
sistence length A0 and probability P0 = (1-x)
2. (b) Two
nearest sites simultaneous occupied have local persistence
length A2 and probability P2 = x
2. (c) Finally, one site
unoccupied and the neighbor occupied have local per-
sistence length A1 and probability P1 = 1 - P0 - P2 =
2x(1-x). The effective persistence length can therefore
be written as
1
AE
=
(1− x)2
A0
+
2x(1 − x)
A1
+
x2
A2
, (28)
and x = r/rmax can be connected to a binding isotherm
as usual.
A last issue must be solved to complete the problem,
both for monotonic and non-monotonic behaviors of the
persistence length: one must write the binding isotherm
as a function of a directly accessible parameter instead
of Cf , as discussed in Section VIA, in order to eliminate
the dependence in using other experimental techniques to
estimate the ligand partitioning between the DNA (Cb)
and the solution (Cf ). Although we have discussed some
approaches to perform this task for intercalators in Sec-
tion VIA, it is clear that a general approach is needed in
order to contemplate the order types of ligands.
In 2012 Siman et al. have firstly proposed a simple
iterative solution of the binding isotherm63, which was
promptly generalized by Cesconetto et al. in 2013 with
the following method. Firstly choose a particular binding
isotherm, for example, the Hill binding isotherm (Eq.
14). One can plug the relations x = r/rmax and Cf =
CT - rCbp = CT - rmaxCbpx in this binding isotherm to
write
x =
[Ki(CT − rmaxCbpx)]
n
1 + [Ki(CT − rmaxCbpx)]n
. (29)
Observe that this equation can be solved numerically
for known values of the constants, returning x for each
value of CT . Therefore, one needs to write a simple al-
gorithm that uses a subroutine to solve Eq. 29 for initial
guessed values of the constants, and uses the results re-
turned for x plugged into Eq. 28 or Eq. 27 to fit the
experimental data of the persistence length A as a func-
tion of CT , by using least squares fitting. With this ap-
proach the problem is completely solved. Observe that
any binding isotherm can be used to get an equation sim-
ilar to Eq. 29, i. e., one needs only to choose a plausible
binding isotherm that captures the physical chemistry of
the interaction.
Below we revisit some results recently obtained with
this approach, showing that in principle it can be used
to study any type of interaction. The only requisite is
that such interaction changes the DNA persistence length
as the ligand binds. All the experimental data were ob-
tained by single molecule stretching performed with opti-
cal tweezers in the entropic regime, with fittings similar
to that shown in Fig. 1 (except those of Fig. 5 - see
ref.175). We also discuss the main features of the physics
and chemistry of the interactions revisited here. A com-
plete detailed discussion can be found in the original ar-
ticles (and the references therein). It is worth to em-
phasize that all optical tweezers measurements were per-
formed in chemical equilibrium, waiting sufficient time
for ligand equilibration before performing the stretching
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experiments. In addition, these measurements were per-
formed with low forces (< 2 pN) and pulling rates (∼ 0.1
µm/s) in order to guarantee that the chemical equilib-
rium is not affected by the stretching forces.
In Fig. 3 we show the experimental data (circles) of
the persistence length of DNA-cisplatin complexes as a
function of drug total concentration in the sample CT .
Observe that, for convenience to fit with Eq. 27, we have
plotted the inverse of the persistence length in this figure
and in all subsequent ones. The fitting with the model
(Eq. 27) is also shown (red solid line). In this case we
have used the Hill binding isotherm (Eq. 14) to perform
the fitting, extracting the physicochemical parametersKi
= (1.6 ± 0.2) × 104 M −1, n = 3.6 ± 0.4, rmax = 0.56 ±
0.06 and A1 = (24 ± 4) nm. These results agree very well
to those presented in ref.97, which were obtained using
another fitting strategy, and as well as to results obtained
from other experimental techniques176,177. In particular,
the Hill exponent n= 3.6 indicates that cisplatin presents
positive cooperativity in its interaction with DNA.
Cisplatin and its analogues carboplatin and oxaliplatin
form one of the most important class os compounds used
in cancer chemotherapies, especially to treat head, neck,
testicular, ovarian and non-small cell lung cancers178.
In aqueous solution, two chloride ions dissociate from
the compound, followed by incorporation of two water
molecules. This is the active state of the drug, which
can bind to DNA179. Many aspects of the DNA-cisplatin
interaction are currently well established in the litera-
ture, such as the mechanism of action of the compound
as an anticancer drug, which consists in damaging the
DNA molecule with adducts that form interstrand and
intrastrand crosslinks180. These crosslinks hinder DNA
replication by introducing strong structural perturba-
tions on the double-helix such as bendings, partial un-
winding and loops126,127,180. These structural pertur-
bations are closely related to the result found for the
Hill exponent (n ∼ 3.6). In fact, a positive coopera-
tivity could be expected in DNA-cisplatin interaction,
since the crosslinks and loops induced in the DNA by
the drug approximate different strand segments as the
drug concentration is increased, therefore increasing the
probability of forming even more crosslinks and loops as
cisplatin binds97,98. A nearly similar mechanism was re-
cently observed for the H-NS binding protein by Dame
et al., which have shown that a cooperative behavior in
this case arises as an intrinsic property of DNA bridging
due to duplex proximity181.
In Fig. 4 we show the experimental data (circles) for
the inverse of the persistence length of DNA complexes
formed with a monovalent cationic β-cyclodextrin (6-
monodeoxy-6-monoamine-β-cyclodextrin) as a function
of drug total concentration in the sample CT , firstly pre-
sented in ref.63. Cyclodextrins (CDs) are cyclic oligosac-
charides composed of D-glucose units joined by glucosidic
linkages. The β subtype consists of seven units and has a
structure that resembles a truncated cone, with hydroxyl
groups localized at the outer surface of the cone. That
FIG. 3. Circles: inverse of the persistence length of DNA-
cisplatin complexes measured by single molecule stretching
experiments. Red solid line: a fitting to the model (Eq. 27)
using the Hill binding isotherm (Eq. 14). From this fitting
we have found the physicochemical parameters Ki = (1.6 ±
0.2) × 104 M −1, n = 3.6 ± 0.4, rmax = 0.56 ± 0.06 and A1
= (24 ± 4) nm. For this data Cbp = 8.9 µM.
FIG. 4. Circles: inverse of the persistence length of DNA-
cyclodextrin complexes measured by single molecule stretch-
ing experiments. Red solid line: a fitting to the model (Eq.
28) using the Hill binding isotherm (Eq. 14). From this fit-
ting we have found the physicochemical parameters Ki = (9
± 1) × 104 M −1, n = 3.7 ± 0.4, A1 = 8.4 ± 1 nm and A2 =
149 ± 21 nm. For this data Cbp = 11 µM.
gives CDs the property to be water-soluble and to have
a relatively hydrophobic inner cavity able to partially or
entirely accommodate polymers forming host-guest inclu-
sion complexes182. Monovalent cationic β-cyclodextrin
is usually obtained by substituting one of the hydroxyl
groups by an amino group. This molecule has been used
for condensing DNA and introducing it into small vesicles
for gene therapy applications183.
Observe in Fig. 4 that for the complexes formed be-
tween DNA and cationic β-cyclodextrin the persistence
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FIG. 5. Circles: inverse of the persistence length of DNA-
HU complexes measured by single molecule stretching exper-
iments (experimental data by van Noort et al.175, error bars
are not available in this case). Red solid line: a fitting to
the model (Eq. 28) using the Hill binding isotherm (Eq. 14).
From this fitting we have found the physicochemical param-
eters Ki = (3.4 ± 0.4) × 10
7 M −1, n = 3.6 ± 0.3, A1 =
(8.5 ± 1) nm and A2 = (115 ± 13) nm. For this data Cbp is
unknown due to the sample preparation procedure63. It was
left as an adjustable parameter, and the fitting returns Cbp ∼
110 nM.
length exhibits a non-monotonic behavior, and therefore
we have used Eq. 28 to fit the data, together with the
Hill binding isotherm (red solid line). We have found the
results Ki = (9 ± 1) × 10
4 M −1, n = 3.7 ± 0.4, A1 =
(8.4 ± 1) nm and A2 = (149 ± 21) nm. The parameter
rmax = 0.67 was known for this ligand such that we have
fixed its value in the fitting63. The value obtained for the
Hill exponent n again indicates that the system is posi-
tively cooperative, in this case forming bound clusters of
∼ 4 drug molecules at the binding sites63.
The results obtained for the bacterial protein HU in
ref.63 are somewhat similar, as shown in Fig. 5. We
have used again Eq. 28 and the Hill binding isotherm to
perform the fitting (red solid line), and the experimental
data (circles) were obtained by van Noort et al. for this
ligand175. From the fitting we have obtained the results
Ki = (3.4 ± 0.4) × 10
7 M −1, n = 3.6 ± 0.3, A1 = (8.5
± 1) nm and A2 = (115 ± 13) nm. Here again, rmax
= 0.11 is a known parameter and was maintained fixed
in the fitting63. For this data Cbp is unknown due to
the sample preparation procedure63. It was left as an
adjustable parameter, and the fitting returns Cbp ∼ 110
nM. Here the fact that the persistence length increases for
high protein concentrations agrees with results obtained
in AFM images, which have shown the formation of rigid
filaments175.
At this point it is necessary to reflect on the use of
the Hill binding isotherm in the analysis of DNA-ligand
systems. The fact that we have found a Hill exponent
n ≫ 1 for cisplatin, cyclodextrin and HU strongly in-
dicates that relevant positive cooperativity is present in
such systems. In fact, binding isotherms with no cooper-
ativity such as the Scatchard model (Eq. 12) or the basic
Neighbor Exclusion Model (NEM) (Eq. 15) do not work
in performing these fittings. The cooperative version of
the neighbor exclusion model (Eq. 16) in principle could
be used, but we were not successful in performing the
fitting in an easy way, founding numerical problems in
solving the equation analogue to Eq. 29 for this bind-
ing isotherm. In fact, the intricacy of Eq. 16 somewhat
limits its applicability in the fitting approaches discussed
in this review. For this reason we use the Hill binding
isotherm, a much simpler equation that also takes into
account cooperativity effects.
The first example of a non-cooperative system stud-
ied with our approach are the DNA complexes formed
with the drug Actinomycin D (ActD), firstly presented
in ref.64. This drug is a DNA ligand clinically used as
an antibiotic and to treat some highly malignant can-
cers, such as gestational trophoblastic disease184, Wilms’
tumor185 and rhabdomyosarcoma186. The drug exhibits
a complex interaction with double-strand DNA, present-
ing two distinct parts which bind to DNA by different
modes: while the phenoxazone ring intercalates, prefer-
entially at the CG base pairs, the cyclic pentapeptide
chains bind to the minor groove, usually forming hydro-
gen bonds with the guanine bases160–163.
Here we clearly have the option of choosing different
binding isotherms to perform the fitting. This fact il-
lustrates the versatility of our approach, which returns
consistent results even for different binding isotherms: it
is required only to choose one that captures the basic
physical chemistry of the system. In fact, if the DNA-
ActD interaction is non-cooperative64, one can choose the
Scatchard model or the basic (non-cooperative) neighbor
exclusion model. Nevertheless, instead of the first option
(Scatchard), we have chosen the Hill binding isotherm
to perform the fitting. If everything is right, one should
find a Hill exponent near unity (n ∼ 1), since in this
case the Hill model is just equivalent to the Scatchard
one. Figure 6 shows the experimental data points (cir-
cles) and the fittings to Eq. 28 with the Hill model (red
solid line) and with the neighbor exclusion model (blue
solid line). From the first fitting (Hill), we find Ki = (1.5
± 0.4) × 106 M −1, n = 1.1 ± 0.2, rmax = 0.11 ± 0.01,
A1 = (15.2 ± 0.6) nm and A2 = (64 ± 25) nm. From
the second fitting (NEM) we find Ki = (4.6 ± 0.5) ×
106 M −1, N = 4 ± 0.5 (the exclusion number for each
bound ActD), A1 = (14 ± 2) nm and A2 = (140 ± 16)
nm. Observe that both fittings explain well the behavior
of the experimental data. The results returned for the
physicochemical parameters, although somewhat depen-
dent on the chosen binding isotherm, are realist. The
relatively high variability on the values found for some of
these parameters is compatible to the variability found
when using different experimental techniques53,187–189.
A relevant question that can be raised at this point
is about the accuracy of our approach to treat systems
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FIG. 6. Circles: inverse of the persistence length of DNA-
ActD complexes measured by single molecule stretching ex-
periments. Red solid line: a fitting to the model (Eq. 28)
using the Hill binding isotherm (Eq. 14). From this fitting
we have found the physicochemical parameters Ki = (1.5 ±
0.4) × 106 M −1, n = 1.1 ± 0.2, rmax = 0.11 ± 0.01, A1 =
(15.2 ± 0.6) nm and A2 = (64 ± 25) nm. Blue solid line: a
fitting to the model (Eq. 28) using the NEM binding isotherm
(Eq. 15). From this fitting we have found the physicochem-
ical parameters Ki = (4.6 ± 0.5) × 10
6 M −1, N = 4 ± 0.5
(the exclusion number for each bound ActD), A1 = (14 ± 2)
nm and A2 = (140 ± 16) nm. For this data Cbp = 10.6 µM.
with more than one binding mode, i. e., with two or
more different sets of physicochemical parameters. Many
compounds interact with DNA in this way, and recently
we have successfully applied our fitting approach to the
fluorescent dye Hoechst 3325865.
The Hoechst stains, also known as bis-benzimides, are
a family of fluorescent dyes largely employed to stain the
DNA molecule in molecular biology applications, allow-
ing one to visualize DNA with fluorescence microscopy.
In addition, these compounds can be potentially used as
anticancer drugs190, since their strong interaction with
DNA can impede the replication of the molecule. Many
experimental techniques were employed over the past
years to study the effects of the Hoechst 33258 sub-
type on the DNA molecule. In particular, it was found
that the ligand binds preferentially to the DNA mi-
nor groove, especially at AT-rich regions191,192. Nev-
ertheless, some authors have proposed that the ligand
presents more than one binding mode to double-strand
(ds) DNA192–194, indicating the possibility of intercala-
tion at GC-rich regions192,195.
With our fitting approach we were able to decouple
the two main binding modes that Hoechst 33258 exhibits
with DNA, by using a binding isotherm expressed as a
sum of two Hill processes. We have determined the two
complete sets of physicochemical parameters for each of
the binding modes. In particular, we have found that
the first binding mode (intercalation) is non-cooperative,
with a Hill exponent ∼ 1, while the second mode (groove
FIG. 7. Circles: inverse of the persistence length of DNA-
hoechst complexes measured by single molecule stretching ex-
periments. Red solid line: a fitting to the model (Eq. 28)
using a sum of two Hill processes as the binding isotherm.
From this fitting we decouple the two binding modes and find
the physicochemical parameters K1 = (1.8 ± 0.4) × 10
6 M
−1, n1 = 1.1 ± 0.3, K2 = (2.4 ± 0.2) × 10
5 M −1, n2 = 7 ±
3, A1 = (300 ± 100) nm and rmax = 0.32 ± 0.02. For this
data Cbp = 20 µM.
binding) is highly positively cooperative, with a Hill ex-
ponent ∼ 7. Such conclusion is in agreement with previ-
ous studies performed by other techniques (equilibrium
dialysis and absorption spectroscopy)193,194. The two
binding modes coexist in the entire concentration range
studied here, but intercalation is dominant for CT < 3
µM while groove binding is dominant for higher concen-
trations. Figure 7 shows the experimental data (circles)
and the fitting (red solid line). We have found that, for
the intercalative binding mode, K1 = (1.8 ± 0.4) × 10
6
M −1, n1 = 1.1 ± 0.3. On the other hand, for minor
groove binding, we found K2 = (2.4 ± 0.2) × 10
5 M
−1, n2 = 7 ± 3. Also, we found A1 = (300 ± 100) nm
and rmax = 0.32 ± 0.02, which are global parameters
independent of the binding mode. The parameter A2 =
28.3 nm was maintained fixed in the fitting since it is
the saturation value of the persistence length, which can
be directly determined from the data of Fig. 7 in this
case. The error bars of the parameters obtained in this
fitting are somewhat higher than those obtained for the
other DNA-ligand systems presented above. This fact
is due to the excess of adjustable parameters used in the
fitting procedure in this case, because we have two differ-
ent binding modes and consequently two sets of binding
parameters.
Finally we show an example of how our fitting ap-
proach can also be used to analyze the contour length
data of DNA complexes formed with ligands. GelRed is
a fluorescent nucleic acid stain designed with the purpose
of replacing the highly toxic ethidium bromide (EtBr)
in gel electrophoresis and other experimental techniques
Extracting physical chemistry from mechanics: a new approach... 16
which depends on the fluorescence of stained DNA. When
bound to DNA, GelRed has the same absorption and
emission spectra of EtBr and, according to its manu-
facturer (Biotium Inc., Hayward, CA, USA), it has the
advantage of being much less toxic and mutagenic196,197.
Figure 8 shows the experimental data of the relative
increase of the contour length Θ = (L - L0)/L0 (cir-
cles), firstly presented in ref.77, and two fittings per-
formed with Eq. 23 and two different binding isotherms:
Scatchard (red solid line) and NEM (blue solid line).
The two fittings are similar, returning equivalent physic-
ochemical parameters and allowing one to conclude that
GelRed interacts with DNA by bis-intercalation77. For
the Scatchard fitting, we have found Ki = (1.8 ± 0.4) ×
107 M −1, rmax = 0.22 ± 0.03 and γ = 2.2 ± 0.1. For the
NEM fitting, we found Ki = (1.8 ± 0.3) × 10
7 M −1, N
= 3.7 ± 0.4 and γ = 1.9 ± 0.1. The results obtained for
this ligand with our fitting approach lead us to conclude
that the GelRed dye is a bis-intercalator. In fact, the ex-
clusion parameter N = 1/rmax indicates that each bound
GelRed molecule effectively occupies ∼ 4 DNA base-
pairs, a value considerably higher than the results found
for most monointercalators, and approximately twice the
result for EtBr (which is ∼ 273–75). The equilibrium asso-
ciation constantKi is also higher than the result obtained
for typical monointercalators (∼ 105 M−1)73–75,147, and
within the range found for most bis-intercalators (107 to
109 M−1)145,198–201. Finally, the result γ ∼ 2 is approx-
imately twice the value obtained for typical monointer-
calators, suggesting that each bound GelRed molecule
increases the DNA contour length by ∼ 0.68 nm, a re-
sult also compatible to typical bis-intercalators198,200.
Observe that the bis-intercalators should increase ap-
proximately twice the DNA contour length per bound
molecule, since each ligand molecule contains two inter-
calating portions.
In summary, we have presented many examples of
DNA-ligand systems analyzed with the proposed fitting
approach. All the results obtained for the physicochemi-
cal parameters are consistent with most studies found in
the literature that have used many different experimen-
tal techniques, from crystallography to fluorescence res-
onance energy transfer53,176,187–189,193,194,202–204. Thus,
our fitting approach allows a direct comparison be-
tween the results obtained from single molecule stretch-
ing experiments to those obtained from typical ensemble-
averaging techniques, which are usually used to char-
acterize the physical chemistry of DNA-ligand interac-
tions. A weakness of the presented approach that can be
pointed concerns the error bars of the physicochemical
parameters obtained from the fitting procedure, which
can be a bit high if the number of adjustable parameters
used in the fitting is high, as in the case of multiple bind-
ing modes. Nevertheless in these cases one can maintain
fixed some parameters previously measured with other
techniques and perform the fitting using only the ad-
justable parameters of interest. In this way, the fitting
approach can be used to compare and verify results ob-
FIG. 8. Circles: experimental data of the relative increase
of the contour length Θ = (L - L0)/L0 of DNA-GelRed com-
plexes. Red solid line: a fitting to Eq. 23 using the Scatchard
binding isotherm (Eq. 13), from which we have found the
physicochemical parameters Ki = (1.8 ± 0.4) × 10
7 M −1,
rmax = 0.22 ± 0.03 and γ = 2.2 ± 0.1. Blue solid line: a
fitting to Eq. 23 using the NEM binding isotherm (Eq. 15),
from which we have found the physicochemical parameters Ki
= (1.8 ± 0.3) × 107 M −1, N = 3.7 ± 0.4 and γ = 1.9 ± 0.1.
For this data Cbp = 2.4 µM.
tained from very different experimental techniques, and
can still be useful in the investigation of DNA-ligand in-
teractions.
VII. CONCLUSIONS
We have reviewed important topics of the field “DNA-
ligand interactions”, from DNA mechanics to DNA-
ligand physical chemistry, emphasizing how one can con-
nect the changes of the mechanical properties of DNA
induced by the binding ligand to the physicochemical in-
formation of such interaction. This type of connection
is extremely relevant because it allows one to perform a
robust characterization of the interaction both from the
point of view of the mechanical properties and of the
physical chemistry of the interaction by using only one
experimental technique: single molecule stretching ex-
periments. Moreover, the possibility of performing such
connection reduces the time and cost required for getting
results about a DNA-ligand system, since less different
equipments are required and the number of experiments
that must be conducted can be considerably reduced.
Furthermore, and more important, it opens the possibil-
ity of comparing the results obtained by means of very
different experimental techniques, in special when com-
paring single molecule techniques to ensemble-averaging
techniques.
In particular, we reviewed a fitting approach recently
proposed by our group to connect the persistence length
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of the DNA-ligand complexes to the physical chemistry
of the interaction. Such approach in principle can be
used for any type of ligand, from drugs to proteins, even
if there are multiple binding modes. However, a test with
sequence-specific ligands205 is still needed. In any case,
the only requisite to try the approach is that the interac-
tion must change the DNA persistence length as the lig-
and binds, which usually occurs for all types of common
interactions (intercalation, covalent binding, electrostatic
driven interactions and groove binding) at least for some
ligand concentration range.
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